The global clinical decision support systems market is projected to reach USD 1,752.0 Million by 2023 from an estimated USD 1,001.9 Million in 2018, growing at a CAGR of 11.8%. This growth can be attributed to factors such as government support & initiatives, growing incidence of medication errors; rising prominence & usage of big data and mhealth tools, high returns on investment for CDSS solutions, and growing adoption of cloud computing in healthcare are driving the growth of this market.
Geographically, the North American market accounted for the largest share of the global clinical decision support systems market in 2017. The large share can be attributed to factors such as the rising demand for quality healthcare delivery, need to curb increasing healthcare expenditure, and implementation of favorable initiatives & regulations are driving the growth of the CDSS market in the US. Additionally, the rising incidence of medical errors in the US necessitate the utilization of advanced solutions such as CDSS in healthcare.
Request FREE Sample Pages: https://www.marketsandmarkets.com/requestsample.asp?id=18085342
Clinical decision support systems market
Reluctance to adopt clinical decision support systems, high investments required for IT infrastructure, data security concerns, and lack of interoperability may impede the growth of this market to some extent.
Wolters Kluwer Health (US), Hearst Health (US), and Elsevier B.V. (Netherlands) are the leading players in the market. Other prominent players include Cerner Corporation (US), McKesson Corporation (US), Epic Systems Corporation (US), MEDITECH (US), Philips Healthcare (Netherlands), International Business Machines (IBM) (US), and Allscripts Healthcare Solutions, Inc. (US).
